Close
Almac
Achema middle east

Production & Manufacturing

Single-Use Fluid Systems Reshaping Biopharma Manufacturing

How Single-Use Fluid Systems Are Reshaping Biopharma Manufacturing The biopharmaceutical industry has witnessed a profound transformation over the past two decades, driven largely by the widespread adoption of single-use systems biopharma technologies. This paradigm shift represents more than a simple...

Scaling Biopharma: Pressure, Flow & Process Control Solutions

Scaling Biopharma Manufacturing: Managing Pressure, Flow & Process Control The transition from laboratory-scale research to commercial-scale manufacturing represents one of the most challenging and critical phases in biopharmaceutical development. The complexity of scaling biopharma manufacturing extends far beyond simple volume...

Sustainable Fluid Management in Pharma for Resource Efficiency

Sustainable Fluid Management in Pharma: Reducing Energy & Resource Waste The pharmaceutical industry stands at a critical juncture where environmental stewardship and operational excellence must converge to create truly sustainable manufacturing practices. As global awareness of environmental challenges intensifies and...

Pressure Protection & Safety in Pharmaceutical Manufacturing

Pressure Protection and Safety in Pharmaceutical Manufacturing Facilities The pharmaceutical manufacturing industry operates under some of the most stringent safety requirements of any industrial sector, with pressure protection pharma manufacturing systems serving as critical safeguards for personnel, equipment, and the...

Sterility in Biopharma with Contamination Control Technology

Ensuring Sterility in Biopharma: Technologies for Contamination Control The pursuit of sterility in biopharmaceutical manufacturing represents one of the most critical challenges facing the industry today. As biologic therapies become increasingly complex and potent, the imperative to maintain absolute contamination...

GSK to Invest $30bn in the U.S. R&D and Manufacturing

GSK plc looks forward to investing $30 billion all across the U.S. in terms of research and development as well as supply chain infrastructure in the next five years. This happens to include a novel $1.2 billion investment when...

$5bn Drug Manufacturing Plant in Virginia by Eli Lilly

Eli Lilly has gone on to announce its plans to build a $5bn drug manufacturing plant in Virginia on September 16. This announcement comes amidst the pressure from President Donald Trump to get more drug manufacturing to the U.S....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »